The objective of this study was to measure the frequency of initially identified ventricular fibrillation or pulseless ventricular tachycardia and survival among patients whose cardiac arrest was witnessed in a public setting or in the home and, in particular, when an AED was applied by way of a bystander.3 We completed a potential, multicenter, population-based cohort study involving patients who were assessed or treated by one or more of 208 ROC EMS agencies and their receiving institutions at seven U.S.Related StoriesNYSCF, CBR collaborate to customize creation of high-quality stem cell linesNYSCF conference to focus on translational stem cell and neuroscience researchStem cell research to help fight congenital brittle bone diseaseThe abstract shows that really small embryonic-like stem cells, rare in peripheral blood normally, can be released in greater quantities from the bone marrow through the use of an FDA approved medication called G-CSF. They can then be collected by an activity called apheresis, an activity used as standard-of-care in blood donations. The authors postulate that G-CSF mobilization could turn into a novel strategy to obtain human being pluripotent stem cells, which are stem cells that have the potential to regenerate all of the cell types of the body.